Everyone knows why companies start up on the OTC. It is all about funding. And funding a start up company always means toxic or equity financing and dilution to begin with. It is not a surprise to me that it has occurred here.
Realistically, the hope is that the company will become successful enough to fund growth by other means and that growth will continue. So far VGID has shown revenue growth quarter over quarter. So, even though the current SP does not entirely show that, the prospect still remains that VGID will become more successful as time and effort will allow.
I'll accumulate and hold my shares in hopes that my speculations and opinions are correct. That is what investing is. Nothing more than a gamble. I like the odds here, better than with other companies. To each his own.
News 
Market Data 
Discover 
AI
